prednisolone has been researched along with Ph 1 Chromosome in 16 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In children with acute lymphoblastic leukemia (ALL), the level of minimal residual disease (MRD) at the end of induction strongly predicts outcome, presumably because it measures both drug sensitivity and the number of leukemic cells requiring elimination." | 2.68 | Relationship between minimal residual disease and outcome in adult acute lymphoblastic leukemia. ( Bradstock, K; Brisco, J; Enno, A; Hughes, E; McCaul, K; Morley, AA; Neoh, SH; Sykes, PJ; Szer, J, 1996) |
| "Concerning hematological disorders, Sweet syndrome often presents in patients with myeloid diseases, but it is rarely observed in patients with lymphoid diseases." | 1.51 | [Recurring Sweet syndrome in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia]. ( Aoki, T; Ishihara, D; Kamimura, T; Umeno, T; Urata, S, 2019) |
| "Imatinib mesylate has dramatically improved the outcome of children with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph* ALL) and is now included as first-line therapy." | 1.42 | Imatinib-induced Severe Hepatitis in a 9-Year-old Girl With Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia. ( Fukushima, H; Fukushima, T; Kobayashi, C; Nanmoku, T; Sakai, A; Satomi, K; Sumazaki, R; Suzuki, R; Tagawa, M, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Innes, AJ | 1 |
| Mullish, BH | 1 |
| Fernando, F | 1 |
| Adams, G | 1 |
| Marchesi, JR | 1 |
| Apperley, JF | 1 |
| Brannigan, E | 1 |
| Davies, F | 1 |
| Pavlů, J | 1 |
| Hirabayashi, S | 1 |
| Hasegawa, D | 1 |
| Yamamoto, K | 1 |
| Nishimura, A | 1 |
| Hosoya, Y | 1 |
| Shuo, T | 1 |
| Kiyokawa, N | 1 |
| Miura, M | 1 |
| Takahashi, N | 1 |
| Manabe, A | 1 |
| Aoki, T | 1 |
| Urata, S | 1 |
| Ishihara, D | 1 |
| Umeno, T | 1 |
| Kamimura, T | 1 |
| Suzuki, R | 1 |
| Kobayashi, C | 1 |
| Sakai, A | 1 |
| Fukushima, H | 1 |
| Tagawa, M | 1 |
| Satomi, K | 1 |
| Nanmoku, T | 1 |
| Sumazaki, R | 1 |
| Fukushima, T | 1 |
| Lim, SN | 1 |
| Joo, YD | 1 |
| Lee, KH | 1 |
| Kim, DY | 1 |
| Lee, JH | 3 |
| Chi, HS | 1 |
| Yun, SC | 1 |
| Lee, WS | 1 |
| Lee, SM | 1 |
| Park, S | 1 |
| Kim, I | 1 |
| Sohn, SK | 1 |
| Moon, JH | 1 |
| Ryoo, HM | 1 |
| Bae, SH | 1 |
| Hyun, MS | 1 |
| Kim, MK | 1 |
| Kim, HJ | 1 |
| Yang, DH | 1 |
| Eom, HS | 1 |
| Lee, GW | 1 |
| Jung, CW | 1 |
| Won, JH | 1 |
| Kim, H | 1 |
| Shin, HJ | 1 |
| Jang, DY | 1 |
| Takata, H | 1 |
| Ikebe, T | 1 |
| Sasaki, H | 1 |
| Miyazaki, Y | 1 |
| Ohtsuka, E | 1 |
| Saburi, Y | 1 |
| Ogata, M | 1 |
| Shirao, K | 1 |
| Koharazawa, H | 1 |
| Kanamori, H | 1 |
| Sakai, R | 2 |
| Hashimoto, C | 1 |
| Takemura, S | 1 |
| Hattori, M | 1 |
| Taguchi, J | 1 |
| Fujimaki, K | 1 |
| Tomita, N | 2 |
| Fujita, H | 1 |
| Fujisawa, S | 2 |
| Harano, H | 1 |
| Ogawa, K | 1 |
| Motomura, S | 1 |
| Maruta, A | 1 |
| Ishigatsubo, Y | 2 |
| Nakajima, Y | 1 |
| Kuwabara, H | 1 |
| Hattori, Y | 1 |
| Ohshima, R | 1 |
| Kitagawa, M | 1 |
| Gupta, M | 1 |
| Kumar, A | 1 |
| Dabadghao, S | 1 |
| Roy, A | 1 |
| Bradburn, M | 1 |
| Moorman, AV | 1 |
| Burrett, J | 1 |
| Love, S | 1 |
| Kinsey, SE | 1 |
| Mitchell, C | 1 |
| Vora, A | 1 |
| Eden, T | 1 |
| Lilleyman, JS | 1 |
| Hann, I | 1 |
| Saha, V | 1 |
| Hallböök, H | 1 |
| Barbany, G | 1 |
| Aleskog, A | 1 |
| Björnberg, A | 1 |
| Larsson, R | 1 |
| Sundström, C | 1 |
| Lindhagen, E | 1 |
| Ohyashiki, K | 1 |
| Ohyashiki, JH | 1 |
| Toyama, K | 1 |
| Brisco, J | 1 |
| Hughes, E | 1 |
| Neoh, SH | 1 |
| Sykes, PJ | 1 |
| Bradstock, K | 1 |
| Enno, A | 1 |
| Szer, J | 1 |
| McCaul, K | 1 |
| Morley, AA | 1 |
| Hongo, T | 1 |
| Yamada, S | 1 |
| Yajima, S | 1 |
| Watanabe, C | 1 |
| Fujii, Y | 1 |
| Kawasaki, H | 1 |
| Yazaki, M | 1 |
| Hanada, R | 1 |
| Horikoshi, Y | 1 |
| Ramakers-van Woerden, NL | 1 |
| Pieters, R | 1 |
| Hoelzer, D | 1 |
| Slater, RM | 1 |
| den Boer, ML | 1 |
| Loonen, AH | 1 |
| Harbott, J | 1 |
| Janka-Schaub, GE | 1 |
| Ludwig, WD | 1 |
| Ossenkoppele, GJ | 1 |
| van Wering, ER | 1 |
| Veerman, AJ | 1 |
| Kuriyama, K | 1 |
| Tomonaga, M | 1 |
| Yao, E | 1 |
| Soda, H | 1 |
| Nonaka, H | 1 |
| Jinnai, I | 1 |
| Matsuo, T | 1 |
| Yoshida, Y | 1 |
| Amenomori, T | 1 |
| Ichimaru, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Medical Research Council Working Party on Leukaemia in Children UK National Lymphoblastic Leukaemia (ALL) Trial[NCT00003437] | Phase 3 | 1,800 participants (Anticipated) | Interventional | 1997-01-31 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for prednisolone and Ph 1 Chromosome
| Article | Year |
|---|---|
Therapy for Philadelphia chromosome-positive acute lymphoblastic leukemia: possible use of interferon on the basis of some novel concepts.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined M | 1993 |
4 trials available for prednisolone and Ph 1 Chromosome
| Article | Year |
|---|---|
Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; D | 2015 |
Long-term outcome of L86 and L97 protocols for adult acute lymphoblastic leukemia.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Fem | 2008 |
Early response to induction is predictive of survival in childhood Philadelphia chromosome positive acute lymphoblastic leukaemia: results of the Medical Research Council ALL 97 trial.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Chil | 2005 |
Relationship between minimal residual disease and outcome in adult acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; | 1996 |
11 other studies available for prednisolone and Ph 1 Chromosome
| Article | Year |
|---|---|
Faecal microbiota transplant: a novel biological approach to extensively drug-resistant organism-related non-relapse mortality.
Topics: Allografts; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacteria; Daunorubicin; Dr | 2017 |
Dasatinib and low-intensity chemotherapy for Philadelphia chromosome-positive acute lymphoblastic leukemia in a child with Down syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Dasatinib; Down Syndrome; Female; Humans; Phi | 2019 |
[Recurring Sweet syndrome in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia].
Topics: Aged; Angina, Unstable; Granulocyte Colony-Stimulating Factor; Humans; Male; Neutropenia; Percutaneo | 2019 |
Imatinib-induced Severe Hepatitis in a 9-Year-old Girl With Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia.
Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Agents; Benzamides; Child; Female; Hepatitis; Humans | 2015 |
Two Elderly Patients with Philadelphia Chromosome Positive Mixed Phenotype Acute Leukemia Who Were Successfully Treated with Dasatinib and Prednisolone.
Topics: Acute Disease; Aged; Dasatinib; Drug Therapy, Combination; Female; Humans; Phenotype; Philadelphia C | 2016 |
Successful treatment of a pregnant woman with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Daunorubicin; Female; Human | 2013 |
In vitro resistance of leukaemic blasts to prednisolone in bcr-abl positive childhood acute lymphoblastic leukaemia.
Topics: Adolescent; Antineoplastic Agents, Hormonal; Burkitt Lymphoma; Child; Child, Preschool; Cytotoxicity | 2002 |
In vitro activity of imatinib in cells from patients with adult acute lymphoblastic leukemia.
Topics: Adult; Antineoplastic Agents; Asparaginase; Benzamides; Cell Survival; Cytarabine; Daunorubicin; Dru | 2005 |
Biological characteristics and prognostic value of in vitro three-drug resistance to prednisolone, L-asparaginase, and vincristine in childhood acute lymphoblastic leukemia.
Topics: Adolescent; Asparaginase; Bone Marrow Cells; Cell Culture Techniques; Child; Child, Preschool; Drug | 1999 |
In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: a report of the Dutch and German Leukemia Study Groups.
Topics: Adult; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Child; Drug R | 2002 |
Dual expression of lymphoid/basophil markers on single blast cells transformed from chronic myeloid leukemia.
Topics: Adult; Basophils; Humans; Leukemia, Myeloid; Lymphocytes; Male; Microscopy, Electron; Philadelphia C | 1986 |